Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

LTGOBullishCorporate Developmentsnews

High materiality8/10

Latigo's LTGO IPO raises $345.6M; Nasdaq listing set for Aug 7

Aug 6, 2026, 8:05 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The upsized $345.6M IPO enhances LTGO's cash runway and reduces near-term dilution risk; successful debut could provide an initial price pop, though biotech IPOs can be volatile.

AI summary

What happened, with direct paths to the underlying reporting

Latigo Biotherapeutics priced an upsized IPO for LTGO at $18 per share, issuing 19.2 million shares to raise about $345.6 million. The offering includes a 30-day option for 2.88 million additional shares. LTGO is slated to trade on Nasdaq starting August 7, with an expected close on August 10, enhancing LTG-001 development funding and corporate liquidity.

Latigo priced upsized IPO at $18 per share.
19.2 million shares offered; gross proceeds about $345.6 million.
Underwriters may exercise 2.88 million additional shares.
LTGO to trade on Nasdaq starting Aug 7; close expected Aug 10.
Lead underwriters: Goldman Sachs, Jefferies, Leerink, Guggenheim.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.